Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed ...

If you have $1,000 to invest right now, you may be wondering where to get started. You could buy stocks that are flying high ...

Ultragenyx and partner Mereo BioPharma’s brittle bone disease trial will continue. Investors had wanted data good enough to ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Merck has reached an agreement to acquire British pharmaceutical company Verona Pharma in a deal worth around $10 billion, ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: MoonLake ...

The industry of biotech is a great place to look for such stocks since so many of these companies are developing cutting-edge ...

Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

Discover why IBB's focused approach makes it preferable to XBI. Learn about their objectives, diversification, and ...

Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.

Oncolytics Biotech Inc shares N.ONCY are trading up $0.09 at $1.01.